ESR1 and breast cancer: Our results demonstrate that induction of SUMOylation by pure AEs contributes to their stronger antiestrogenicity compared with SERMs, and that a naturally occurring mutation that abrogates ERα SUMOylation leads to increased transcription of estrogen target genes in the presence of fulvestrant in BC cells.